Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 80% ± 21% | |
peripheral blood | 18 studies | 93% ± 10% | |
intestine | 14 studies | 77% ± 26% | |
brain | 12 studies | 38% ± 21% | |
eye | 10 studies | 59% ± 23% | |
kidney | 8 studies | 80% ± 20% | |
liver | 7 studies | 66% ± 26% | |
bone marrow | 6 studies | 83% ± 17% | |
pancreas | 5 studies | 84% ± 19% | |
uterus | 5 studies | 90% ± 13% | |
lymph node | 4 studies | 98% ± 1% | |
placenta | 4 studies | 88% ± 18% | |
heart | 4 studies | 41% ± 19% | |
adipose | 4 studies | 45% ± 30% | |
esophagus | 4 studies | 72% ± 22% | |
prostate | 4 studies | 86% ± 24% | |
breast | 4 studies | 96% ± 4% | |
skin | 3 studies | 81% ± 19% | |
stomach | 3 studies | 56% ± 26% | |
thymus | 3 studies | 84% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 28008.51 | 1445 / 1445 | 100% | 259.62 | 183 / 183 |
liver | 100% | 14474.17 | 226 / 226 | 100% | 230.48 | 406 / 406 |
ovary | 100% | 56548.76 | 180 / 180 | 100% | 492.40 | 430 / 430 |
pancreas | 100% | 25741.12 | 328 / 328 | 100% | 234.71 | 178 / 178 |
uterus | 100% | 28700.38 | 170 / 170 | 100% | 391.77 | 459 / 459 |
thymus | 100% | 21793.65 | 653 / 653 | 100% | 300.88 | 604 / 605 |
prostate | 100% | 26660.50 | 245 / 245 | 100% | 398.85 | 501 / 502 |
stomach | 100% | 22684.01 | 359 / 359 | 100% | 327.83 | 285 / 286 |
intestine | 100% | 27776.30 | 966 / 966 | 100% | 389.75 | 525 / 527 |
bladder | 100% | 27769.57 | 21 / 21 | 100% | 374.64 | 502 / 504 |
lung | 100% | 21259.18 | 576 / 578 | 100% | 342.03 | 1154 / 1155 |
breast | 100% | 33196.56 | 459 / 459 | 99% | 271.36 | 1112 / 1118 |
kidney | 100% | 23786.45 | 89 / 89 | 99% | 239.49 | 895 / 901 |
brain | 99% | 12676.55 | 2628 / 2642 | 100% | 204.27 | 702 / 705 |
skin | 100% | 37747.98 | 1809 / 1809 | 99% | 307.45 | 466 / 472 |
adrenal gland | 100% | 21020.86 | 258 / 258 | 97% | 185.31 | 222 / 230 |
adipose | 100% | 29428.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 654.92 | 29 / 29 |
spleen | 100% | 27553.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 323.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 218.00 | 1 / 1 |
blood vessel | 100% | 22107.88 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 14823.59 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 13954.94 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 409.47 | 78 / 80 |
peripheral blood | 52% | 17555.61 | 481 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
GO_0006412 | Biological process | translation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_1902255 | Biological process | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0042274 | Biological process | ribosomal small subunit biogenesis |
GO_0050821 | Biological process | protein stabilization |
GO_0001843 | Biological process | neural tube closure |
GO_1904667 | Biological process | negative regulation of ubiquitin protein ligase activity |
GO_0014033 | Biological process | neural crest cell differentiation |
GO_0006364 | Biological process | rRNA processing |
GO_0002181 | Biological process | cytoplasmic translation |
GO_0005730 | Cellular component | nucleolus |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0022627 | Cellular component | cytosolic small ribosomal subunit |
GO_0005840 | Cellular component | ribosome |
GO_0016020 | Cellular component | membrane |
GO_0032040 | Cellular component | small-subunit processome |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_1990948 | Molecular function | ubiquitin ligase inhibitor activity |
GO_0048027 | Molecular function | mRNA 5'-UTR binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0003723 | Molecular function | RNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPS7 |
Protein name | Small ribosomal subunit protein eS7 (40S ribosomal protein S7) 40S ribosomal protein S7 |
Synonyms | |
Description | FUNCTION: Component of the small ribosomal subunit . The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell . Required for rRNA maturation . Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome . . |
Accessions | ENST00000646909.1 ENST00000403564.5 A0A2R8Y623 B5MCP9 ENST00000407445.8 ENST00000647131.1 ENST00000645674.2 ENST00000406376.1 P62081 ENST00000462576.5 |